Product image of Niquitin Minis (Nicotine) supplied by GNH India

Niquitin Minis

Active Ingredient:
Nicotine
Origin:
EU

Niquitin Minis (Nicotine)

Nicotine, the active ingredient in Niquitin Minis, is a nicotinic receptor agonist presented as an oromucosal product for oral mucosa use. It is used to help adult smokers manage nicotine withdrawal symptoms and cravings during smoking cessation attempts.

GNH India supplies Niquitin Minis as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Manufacturer / TM Owner

Omega Pharma Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Niquitin Minis is a nicotinic receptor agonist indicated for conditions related to tobacco use and nicotine dependence.

  • Smoking cessation: assists adult smokers in reducing withdrawal symptoms and cravings while quitting tobacco.
  • Nicotine dependence: supports gradual reduction of nicotine intake in individuals with established dependence.
  • Relapse prevention: helps maintain abstinence after an initial quit attempt by providing controlled nicotine exposure.

How It Works

  • Nicotine in Niquitin Minis binds to and stimulates nicotinic acetylcholine receptors located in the oral mucosa. This activation mimics the pharmacologic effects of inhaled tobacco nicotine, delivering a controlled dose that reduces the neurochemical imbalance caused by abrupt cessation, thereby alleviating withdrawal symptoms and decreasing the urge to smoke.

Side Effects

Niquitin Minis may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Mouth irritation: mild soreness or tingling in the oral cavity.
  • Nausea: occasional feeling of queasiness after use.
  • Headache: mild to moderate headache during the initial days of therapy.

Serious or Rare Side Effects

  • Allergic reaction: rash, swelling, or difficulty breathing.
  • Cardiovascular events: palpitations, hypertension, or chest discomfort.
  • Severe hypotension: marked drop in blood pressure leading to dizziness or fainting.

Precautions & Warnings

Before using Niquitin Minis, consider the following safety measures.

  • Cardiovascular assessment: evaluate heart disease or uncontrolled hypertension before initiating therapy.
  • Pregnancy and lactation: use only if the prescriber determines potential benefits outweigh unknown risks.
  • Concomitant nicotine products: avoid using other nicotine replacement therapies to prevent overdose.
  • Existing medical conditions: exercise caution in patients with diabetes, gastrointestinal disorders, or psychiatric illnesses.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Niquitin Minis can interact with several medication classes; awareness of these interactions helps ensure safe use.

Major Interactions (Avoid)

  • Other nicotine replacement therapy: risk of nicotine overdose.
  • CYP2A6 inhibitors (e.g., methoxsalen): may increase systemic nicotine levels.
  • Insulin: nicotine can affect glucose metabolism, requiring dose adjustments.

Moderate Interactions (Monitor Closely)

  • Antidepressants (e.g., bupropion): additive central nervous system stimulation.
  • Beta‑blockers: nicotine‑induced tachycardia may be masked.
  • Antihypertensives: nicotine may diminish blood‑pressure‑lowering effects.

Frequently Asked Questions

Niquitin Minis is an over‑the‑counter nicotinic receptor agonist designed to help adult smokers manage nicotine withdrawal symptoms and cravings during smoking cessation. It provides a controlled oral dose of nicotine to support quitting attempts and reduce the likelihood of relapse.

The nicotine in Niquitin Minis binds to nicotinic acetylcholine receptors in the oral mucosa, producing a mild pharmacologic effect similar to that of inhaled tobacco nicotine. This controlled stimulation eases the neurochemical imbalance that occurs when tobacco use stops, thereby lessening cravings and withdrawal discomfort.

The specific dose and dosing schedule for Niquitin Minis are determined by the prescribing healthcare professional based on the individual’s smoking history, level of dependence, and treatment goals. Patients should follow the prescriber’s instructions and not alter the regimen without medical advice.

Safety data for nicotine use in pregnancy and lactation are limited. Niquitin Minis should only be used if the prescriber judges that the potential benefits outweigh any possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. The team then replies with pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Niquitin Minis delivers nicotine via the oral mucosa, similar to nicotine gum or lozenges, but its formulation may differ in release profile and taste. Compared with transdermal patches, it provides a faster onset of action and allows flexible dosing throughout the day. Choice of product depends on patient preference, tolerability, and clinical guidance.

Store Niquitin Minis at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Niquitin Minis is administered orally by placing the tablet or lozenge in the mouth and allowing it to dissolve slowly against the oral mucosa. Do not chew or swallow whole; the product should remain in contact with the mucosal surface for optimal nicotine absorption.

Serious risks include allergic reactions such as rash, swelling, or breathing difficulty, and cardiovascular events like palpitations, hypertension, or chest pain. If any of these occur, discontinue use immediately and seek medical attention.

Individuals with known hypersensitivity to nicotine, uncontrolled hypertension, recent myocardial infarction, or those currently using other nicotine replacement products should avoid Niquitin Minis unless directed otherwise by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nicotine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT